by Clinical Neuropsychologist Online | Tuesday, July 28, 2026 | Dementia
Abstract In response to a Cochrane review (published in April 2026) on the clinical trials of monoclonal antibodies targeting beta amyloid, this perspective outlines a number of critiques. The scientists, methodologists, subject-matter experts, and clinicians on this...
by Clinical Neuropsychologist Online | Tuesday, July 28, 2026 | Dementia
Abstract Cochrane Reviews are widely regarded as the gold standard for evidence synthesis, yet analytical framing influences interpretation. A recent Cochrane review of amyloid beta–targeting monoclonal antibodies pools mechanistically and biologically heterogenous...
by Clinical Neuropsychologist Online | Tuesday, July 28, 2026 | Paediatric Neuropsychology
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | July 28, 2026 Neuro-Paediatric Previous Page
by Clinical Neuropsychologist Online | Tuesday, July 28, 2026 | Neurorehabilitation
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | July 28, 2026 Neuro-Rehab Previous Page
by Clinical Neuropsychologist Online | Tuesday, July 28, 2026 | Neuropsychology (general)
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | July 28, 2026 Neuro-General Previous Page
